Búsqueda de un ensayo clínico
Otra(s) opcion(es) de búsqueda
8 Resultado(s)
Ensayo clínico en reclutamiento
= 
; Ensayos clínico en curso
= 
; Financiado por un miembro del IRDiRC = 
; Miembro de una ERN = 
Ensayo(s) clínico(s) nacional(es)
ALEMANIA
Bayern
REGENSBURG
Der Einfluss von Timolol Nasenspray auf Epistaxis bei Morbus Osler Patienten
Universitätsklinikum Regensburg
Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde
CANADA
Ontario
TORONTO
Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
St. Michael's Hospital
Keenan Research Centre
FRANCIA
AUVERGNE-RHONE-ALPES
BRON
BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). A National, Multicenter Phase III Study
CHU de Lyon HCL - GH Est-Hôpital Femme Mère Enfant
Service de génétique
FRANCIA
ILE-DE-FRANCE
PARIS
PREMILOC : Early Prevention of Broncho-pulmonary Dysplasia and Neonatal Mortality in Very Preterm Infants Using Low Dose of Hydrocortisone: a Randomized Controlled Trial
CHU Paris - Hôpital Robert Debré
Equipe "Physiopathologie et neuroprotection des atteintes du cerveau en développement"
ITALIA
LOMBARDIA
PAVIA
Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (Phase II)- IT
Fondazione IRCCS Policlinico San Matteo
Clinica Medica III
PAISES BAJOS (LOS)
Gelderland
NIJMEGEN
An Uncontrolled, Pilot-study Assessing the Efficacy of Octreotide Long-acting Release to Decrease Transfusion Requirements and Endoscopy Frequency in Patients With Rendu-Osler-Weber and Gastrointestinal Bleeding
Radboudumc - Radboud universitair medisch centrum
Afdeling Maag-, Darm- en Leverziekten
PAISES BAJOS (LOS)
Noord-Holland
AMSTERDAM
The SToP-BPD study: Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants - NL
Amsterdam UMC, locatie AMC
Afdeling Intensive Care Neonatologie
Ensayo(s) clínico(s) multinacional(es)
PAISES BAJOS (LOS)
Noord-Holland
AMSTERDAM